{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:24:25Z","timestamp":1784067865922,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK07245"],"award-info":[{"award-number":["T32DK07245"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mcna.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T12:14:12Z","timestamp":1631189652000},"page":"1047-1063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Approach to the Patient with an Incidental Adrenal Mass"],"prefix":"10.1016","volume":"105","author":[{"given":"Xin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2018-01707","article-title":"Pheochromocytoma characteristics and behavior differ depending on method of discovery","volume":"104","author":"Gruber","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.009_bib2","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"Supplement 1","key":"10.1016\/j.mcna.2021.06.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib5","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MED.0000000000000159","article-title":"Update on subclinical Cushing\u2019s syndrome","volume":"22","author":"Nieman","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-13-0848","article-title":"Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications","volume":"171","author":"Vassilatou","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies--a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"issue":"14","key":"10.1016\/j.mcna.2021.06.009_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9628","key":"10.1016\/j.mcna.2021.06.009_bib11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.surg.2008.07.025","article-title":"The role of radiologic studies in the evaluation and management of primary hyperaldosteronism","volume":"144","author":"White","year":"2008","journal-title":"Surgery"},{"issue":"9486","key":"10.1016\/j.mcna.2021.06.009_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/jc.2018-01532","article-title":"CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma","volume":"104","author":"Canu","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.009_bib19","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.mayocp.2019.03.030","article-title":"Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis","volume":"94","author":"Buitenwerf","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib21","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2010-0633","article-title":"Is subclinical Cushing\u2019s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined","volume":"95","author":"Stewart","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12020-014-0387-7","article-title":"DHEAS for the prediction of subclinical Cushing\u2019s syndrome: perplexing or advantageous?","volume":"48","author":"Yener","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib23","first-page":"786","article-title":"Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas","volume":"102","author":"Dennedy","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11154-011-9157-5","article-title":"Primary aldosteronism and a Texas two-step","volume":"12","author":"Auchus","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"8","key":"10.1016\/j.mcna.2021.06.009_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary Aldosteronism: Practical Approach to Diagnosis and Management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A\u00a0systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","author":"Sawka","year":"2004","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0889-8529(05)70115-8","article-title":"Subclinical Cushing\u2019s syndrome","volume":"29","author":"Reincke","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.009_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jch.12523","article-title":"Unadjusted Plasma Renin Activity as a \u201cFirst-Look\u201d Test to Decide Upon Further Investigations for Primary Aldosteronism","volume":"17","author":"Rye","year":"2015","journal-title":"J\u00a0Clin Hypertens Greenwich Conn"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.009_bib29","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mcna.2021.06.009_bib30","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.009_bib33","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib34","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing\u2019s syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing\u2019s syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-09-0775","article-title":"Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?","volume":"162","author":"Eller-Vainicher","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.surg.2015.05.034","article-title":"Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol","volume":"159","author":"Ortiz","year":"2016","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Lib\u00e8","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.mcna.2021.06.009_bib42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40265-019-01128-7","article-title":"Medical Management of Cushing\u2019s Syndrome: Current and Emerging Treatments","volume":"79","author":"Hinojosa-Amaya","year":"2019","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.mcna.2021.06.009_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.009_bib44","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.009_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4158\/EP09351.OR","article-title":"Change in adrenal mass size as a predictor of a malignant tumor","volume":"16","author":"Pantalone","year":"2010","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2005.11.005","article-title":"Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?","volume":"202","author":"Sturgeon","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"issue":"8","key":"10.1016\/j.mcna.2021.06.009_bib50","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature","volume":"171","author":"Boland","year":"1998","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1148\/radiology.217.3.r00dc29798","article-title":"Characterization of Indeterminate (Lipid-poor) Adrenal Masses: Use of Washout Characteristics at Contrast-enhanced CT","volume":"217","author":"Pe\u00f1a","year":"2000","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1148\/radiology.207.2.9577483","article-title":"Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT","volume":"207","author":"Szolar","year":"1998","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.200.3.8756925","article-title":"Adrenal adenomas: relationship between histologic lipid and CT and MR findings","volume":"200","author":"Korobkin","year":"1996","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.009_bib55","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiol.2313030676","article-title":"Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role?","volume":"231","author":"Haider","year":"2004","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.009_bib56","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiol.2502080219","article-title":"Adrenal Nodules at FDG PET\/CT in Patients Known to Have or Suspected of Having Lung Cancer: A Proposal for an Efficient Diagnostic Algorithm","volume":"250","author":"Brady","year":"2009","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.009_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acra.2007.01.009","article-title":"Differentiating Adrenal Adenomas From Nonadenomas Using 18F-FDG PET\/CT: Quantitative and Qualitative Evaluation","volume":"14","author":"Caoili","year":"2007","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib59","first-page":"32","article-title":"18F-FDG PET\/CT in the Evaluation of Adrenal Masses","volume":"47","author":"Metser","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.009_bib60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.13448","article-title":"Diagnostic performance of unenhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","article-title":"[123I]-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation","volume":"69","author":"Bhatia","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.009_bib62","first-page":"685","article-title":"[123I]metaiodobenzylguanidine and [111In]octreotide uptake in begnign and malignant pheochromocytomas","volume":"86","author":"van der Harst","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2021.06.009_bib63","author":"Young"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T19:43:23Z","timestamp":1672343003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252100095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S002571252100095X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.06.009","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to the Patient with an Incidental Adrenal Mass","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}